![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
U Jaehde, MW Langemeijer, AG de Boer and DD Breimer
Center for Bio-Pharmaceutical Sciences, Leiden University, The Netherlands.
The disposition of ciprofloxacin and pefloxacin in the rat cerebrospinal fluid (CSF) was investigated after i.v. and i.c.v. administration. After injection into the lateral ventricle, the terminal half-life of pefloxacin was shorter than that of ciprofloxacin. After i.v. infusions, the relative CSF exposure, expressed as CSF: area under the plasma concentration time curve ratio, were found to be 10.4 +/- 2.8% for ciprofloxacin and 42.4 +/- 3.0% for pefloxacin. The unit impulse response methodology was applied in order to assess the CSF transport profile. The plasma-CSF transport clearance of pefloxacin and the total amount of drug transported into the CSF were significantly higher compared with ciprofloxacin. Although pefloxacin exhibited a linear CSF transport profile, the plasma-CSF transport clearance of ciprofloxacin was found to be nonlinear at the dose level studied. Pefloxacin was converted in the brain to the active metabolite norfloxacin (N-desmethyl pefloxacin). The difference in CSF exposure of both quinolones and the presence of active metabolites of N- methylated quinolones in the CSF may be of clinical relevance in the treatment of CNS infections, but differences in antimicrobial activity have to be taken into account as well.
This article has been cited by other articles:
|
|
 |
|
  K. Naruhashi, I. Tamai, N. Inoue, H. Muraoka, Y. Sai, N. Suzuki, and A. Tsuji Involvement of Multidrug Resistance-Associated Protein 2 in Intestinal Secretion of Grepafloxacin in Rats Antimicrob. Agents Chemother., February 1, 2002; 46(2): 344 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Marchand, C. Pariat, A. Boulanger, S. Bouquet, and W. Couet A pharmacokinetic/pharmacodynamic approach to show that not all fluoroquinolones exhibit similar sensitivity toward the proconvulsant effect of biphenyl acetic acid in rats J. Antimicrob. Chemother., December 1, 2001; 48(6): 813 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Tamai, J. Yamashita, Y. Kido, A. Ohnari, Y. Sai, Y. Shima, K. Naruhashi, S. Koizumi, and A. Tsuji Limited Distribution of New Quinolone Antibacterial Agents into Brain Caused by Multiple Efflux Transporters at the Blood-Brain Barrier J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 146 - 152. [Abstract] [Full Text]
|
|
|
|
|
|
A. Delon, S. Bouquet, F. Huguet, V. Brunet, P. Courtois, and W. Couet Pharmacokinetic-Pharmacodynamic Contributions to the Convulsant Activity of Fluoroquinolones in Rats Antimicrob. Agents Chemother., June 1, 1999; 43(6): 1511 - 1515. [Abstract] [Full Text]
|
|
|
|
|
|
A. Delon, C. Pariat, P. Courtois, S. Bouquet, and W. Couet A New Approach for Early Assessment of the Epileptogenic Potential of Quinolones Antimicrob. Agents Chemother., October 1, 1998; 42(10): 2756 - 2758. [Abstract] [Full Text]
|
|
|
|
|
|
T. Ooie, T. Terasaki, H. Suzuki, and Y. Sugiyama Kinetic Evidence for Active Efflux Transport across the Blood-Brain Barrier of Quinolone Antibiotics J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 293 - 304. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Ooie, T. Terasaki, H. Suzuki, and Y. Sugiyama Quantitative Brain Microdialysis Study on the Mechanism of Quinolones Distribution in the Central Nervous System Drug Metab. Dispos., July 1, 1997; 25(7): 784 - 789. [Abstract] [Full Text]
|
|
|
|
|
|
A. Delon, F. Huguet, P. Courtois, J.-M. Vierfond, S. Bouquet, and W. Couet Pharmacokinetic-Pharmacodynamic Contributions to the Convulsant Activity of Pefloxacin and Norfloxacin in Rats J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 983 - 987. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
